Alzamend Neuro, Inc. lost $2.63 per diluted share in fiscal year 2026. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to a loss of $2.30 per diluted share. The table below carries 7 fiscal years, from 2020 to 2026, and the quarters Alzamend Neuro, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Alzamend Neuro, Inc.'s diluted earnings per share in fiscal year 2026?
Alzamend Neuro, Inc. lost $2.63 per diluted share in fiscal year 2026.
What is Alzamend Neuro, Inc.'s diluted earnings per share over the last twelve months?
Alzamend Neuro, Inc. (ALZN) reported a loss of $2.30 per diluted share over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.
What was Alzamend Neuro, Inc.'s diluted earnings per share in the most recent quarter?
Alzamend Neuro, Inc. (ALZN) reported -$0.68 in diluted earnings per share in Q1 2027.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Alzamend Neuro, Inc. (ALZN) reported on that line in every period on record.
